| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ADAPY (ADAPY) has 4 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. ADAPY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 100.37M | $4.01M | - | |
| COO | 986.4K | $39.5K | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 | Lunger John | Chief Patient Supply Officer | Sell | 1,907 | $4.26 | $8,133.16 | -37.6% | |
| Jun 28, 2021 | Rawcliffe Adrian | Chief Executive Officer | Sell | 2,794 | $4.37 | $12,209.78 | -47.7% | |
| Jun 1, 2021 | Alleva Lawrence M | Director | Buy | 12,600 | $0.79 | $9,954.00 | New | |
| Jan 19, 2021 | Norry Elliot | Chief Medical Officer | Sell | 2,111 | $5.67 | $11,968.31 | -37.4% | |
| Jan 19, 2021 | Lunger John | Chief Patient Supply Officer | Sell | 4,358 | $5.67 | $24,707.68 | -37.2% | |
| Jan 19, 2021 | Rawcliffe Adrian | Chief Executive Officer | Sell | 9,879 | $5.67 | $56,008.99 | -42.2% | |
| Jan 12, 2021 | Bertrand William C Jr | Chief Operating Officer | Sell | 2,234 | $6.15 | $13,744.01 | -37.2% | |
| Jan 12, 2021 | Lunger John | Chief Patient Supply Officer | Sell | 1,058 | $6.15 | $6,509.03 | -37.5% | |
| Jan 12, 2021 | Norry Elliot | Chief Medical Officer | Sell | 841 | $6.15 | $5,174.00 | -37.6% | |
| Jan 12, 2021 | Rawcliffe Adrian | Chief Executive Officer | Sell | 2,707 | $6.15 | $16,654.01 | -42.3% |